Regarding LOXL3, substantial information reinforces its role in ECM remodeling linking deregulated LOXL3 to different connective tissue disorders [16, 18–21]; however, LOXL3 involvement in cancer has not been systematically investigated. The gene discussed is LOXL3; the disease is connective tissue disorder.